Concern over immunosuppressant skin medications

  • Date: 18 March 2020

A STATEMENT from the British Association of Dermatologists (BAD) has acknowledged concerns about  COVID-19 risk among people taking medicines that affect the immune system, such as biologic therapies or immunosuppressants.

The organisation states it is not aware of any good evidence that these people are at a greater risk of getting COVID-19 or having a more severe form of the illness, although this advice may change as more is discovered about the nature of the new condition. It advises clinicians and patients to check NHS advice regularly.

The BAD advises that creams used for skin conditions, in the correct quantities recommended by dermatologists or GPs, are not likely to increase the risks of getting COVID-19 or having a more severe form of the illness.

Up-to-date advice and information is available on the on the NHS Coronavirus (COVID-19) website. https://www.nhs.uk/conditions/coronavirus-covid-19/

This page was correct at the time of publication. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.

Save this article

Save this article to a list of favourite articles which members can access in their account.

Save to library

Related Content

Raising concerns about patient safety

Coroner's inquests

Equality, diversity and inclusion workshop

For registration, or any login issues, please visit our login page.